[HTML][HTML] Tularemia: a re-emerging tick-borne infectious disease
Tularemia is a bacterial disease of humans, wild, and domestic animals. Francisella
tularensis, which is a Gram-negative coccobacillus-shaped bacterium, is the causative agent …
tularensis, which is a Gram-negative coccobacillus-shaped bacterium, is the causative agent …
[HTML][HTML] Link between antibiotic persistence and antibiotic resistance in bacterial pathogens
W Eisenreich, T Rudel, J Heesemann… - Frontiers in cellular and …, 2022 - frontiersin.org
Both, antibiotic persistence and antibiotic resistance characterize phenotypes of survival in
which a bacterial cell becomes insensitive to one (or even) more antibiotic (s). However, the …
which a bacterial cell becomes insensitive to one (or even) more antibiotic (s). However, the …
Efficacy of intravenously administered gepotidacin in cynomolgus macaques following a Francisella tularensis inhalational challenge
C Jakielaszek, JJ Hilliard, F Mannino… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
Francisella tularensis (F. tularensis) is a Centers for Disease Control (CDC) category “A”
Gram-negative biothreat pathogen. Inhalation of F. tularensis can cause pneumonia and …
Gram-negative biothreat pathogen. Inhalation of F. tularensis can cause pneumonia and …
Antimicrobial Susceptibility of Francisella tularensis Isolates in the United States, 2009–2018
J Choat, J Young, JM Petersen… - Clinical Infectious …, 2024 - academic.oup.com
Francisella tularensis is the causative agent of tularemia. We tested the susceptibility of 278
F. tularensis isolates from the United States received during 2009–2018 to 8 antimicrobial …
F. tularensis isolates from the United States received during 2009–2018 to 8 antimicrobial …
[HTML][HTML] Tularemia treatment: experimental and clinical data
M Maurin, L Pondérand, A Hennebique… - Frontiers in …, 2024 - frontiersin.org
Tularemia is a zoonosis caused by the Gram negative, facultative intracellular bacterium
Francisella tularensis. This disease has multiple clinical presentations according to the route …
Francisella tularensis. This disease has multiple clinical presentations according to the route …
[HTML][HTML] Evolution of Antibiotic Resistance in Surrogates of Francisella tularensis (LVS and Francisella novicida): Effects on Biofilm Formation and Fitness
FV Biot, BA Bachert, KD Mlynek, RG Toothman… - Frontiers in …, 2020 - frontiersin.org
Francisella tularensis, the causative agent of tularemia, is capable of causing disease in a
multitude of mammals and remains a formidable human pathogen due to a high morbidity …
multitude of mammals and remains a formidable human pathogen due to a high morbidity …
[PDF][PDF] Tularaemia–a diagnostic challenge
M Wawszczak, B Banaszczak… - Annals of Agricultural …, 2022 - bibliotekanauki.pl
Introduction. Tularaemia is an infrequently occurring disease in Poland. It has therefore
rarely been taken into account in the differential diagnosis of skin lesions, lymphadenitis, or …
rarely been taken into account in the differential diagnosis of skin lesions, lymphadenitis, or …
Множественная лекарственная устойчивость клеток F. tularensis subsp. holarctica, анализ эпизоотологической и эпидемиологической ситуации по туляремии …
ТЮ Кудрявцева, ВП Попов… - Проблемы особо …, 2023 - journal.microbe.ru
Аннотация В обзоре кратко изложена информация о врожденной способности клеток
возбудителя туляремии Francisella tularensis subsp. holarctica сопротивляться …
возбудителя туляремии Francisella tularensis subsp. holarctica сопротивляться …
[HTML][HTML] Genetic Determinants of Antibiotic Resistance in Francisella
SJ Kassinger, ML Van Hoek - Frontiers in Microbiology, 2021 - frontiersin.org
Tularemia, caused by Francisella tularensis, is endemic to the northern hemisphere. This
zoonotic organism has historically been developed into a biological weapon. For this Tier 1 …
zoonotic organism has historically been developed into a biological weapon. For this Tier 1 …
Treatment outcome of severe respiratory type B tularemia using fluoroquinolones
M Widerström, S Mörtberg, M Magnusson… - Clinical Infectious …, 2024 - academic.oup.com
Background Fluoroquinolones lack approval for treatment of tularemia but have been used
extensively for milder illness. Here, we evaluated fluoroquinolones for severe illness …
extensively for milder illness. Here, we evaluated fluoroquinolones for severe illness …